We serve Acetic Acid 3-Methoxybutyl Ester CAS:4435-53-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Acetic Acid 3-Methoxybutyl Ester
CAS.NO:4435-53-4
Molecular Formula:C7H14O3
Molecular Weight:146.18400
Synonyms:
3-Methoxybutyl acetate
Physical and Chemical Properties:
Density: 0.96 g / cm3
Boiling point: 172 ° C
Flash point: 62 ° C
Refractive index: 1.406
Specification:
Appearance: Colorless liquid
Purity:≥98.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like Acetic Acid 3-Methoxybutyl Ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Methoxybutyl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetic Acid 3-Methoxybutyl Ester Use and application,3-Methoxybutyl acetate technical grade,usp/ep/jp grade.
Related News: GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.6,7-Dimethoxy-3,4-dihydroquinazoline-4-one manufacturer GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.4-N-PENTYLOXYBENZALDEHYDE supplier Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.3,5-Dichlorobenzoyl chloride vendor Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.
